Department of Environmental Health & Center for Environmental Genetics, University of Cincinnati College of Medicine, 3223 Eden Avenue, Cincinnati, OH 45267-0056, USA.
Epigenomics. 2010 Feb;2(1):87-104. doi: 10.2217/epi.09.45.
Arsenic is a nonmutagenic human carcinogen that induces tumors through unknown mechanisms. A growing body of evidence suggests that its carcinogenicity results from epigenetic changes, particularly in DNA methylation. Changes in gene methylation status, mediated by arsenic, have been proposed to activate oncogene expression or silence tumor suppressor genes, leading to long-term changes in the activity of genes controlling cell transformation. Mostly descriptive, and often contradictory, studies have demonstrated that arsenic exposure is associated with both hypo- and hyper-methylation at various genetic loci in vivo or in vitro. This ambiguity has made it difficult to assess whether the changes induced by arsenic are causally involved in the transformation process or are simply a reflection of the altered physiology of rapidly dividing cancer cells. Here, we discuss the evidence supporting changes in DNA methylation as a cause of arsenic carcinogenesis and highlight the strengths and limitations of these studies, as well as areas where consistencies and inconsistencies exist.
砷是一种非致突变性的人类致癌物,其通过未知机制诱导肿瘤。越来越多的证据表明,其致癌性源自于表观遗传变化,特别是 DNA 甲基化。砷介导的基因甲基化状态的改变被提出可以激活癌基因表达或沉默肿瘤抑制基因,导致控制细胞转化的基因活性发生长期变化。大量描述性的、且常常相互矛盾的研究表明,砷暴露与体内或体外各种遗传基因座的低甲基化和高甲基化有关。这种不确定性使得很难评估砷诱导的变化是否与转化过程有因果关系,或者是否仅仅是快速分裂的癌细胞改变的生理状态的反映。在这里,我们讨论了支持 DNA 甲基化变化作为砷致癌原因的证据,并强调了这些研究的优点和局限性,以及存在一致性和不一致性的领域。